丹德罗宾A是Dendrobium nobile的活性成分,通过抑制核因子kappa-B的信号传导来对抗肝细胞癌
Yaping Yu1, Yonghao Fan1, Wenli Mei2
1Key Laboratory of Emergency and Trauma of Ministry of Education, Engineering Research Center for Hainan Biological Sample Resources of Major Diseases & the Department of Oncology of the First Affiliated Hospital, Hainan Medical University, Haikou 570102, PR China.
概括
来自Dendrobium nobile的Dendrobin A通过阻断NF-κB通路,有效地抑制肝细胞癌 (HCC). 这项研究为在HCC治疗中使用Dendrobium nobile提供了科学基础.
科学领域:
- 药理学和传统医学的医学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 登德罗宾A是Dendrobium nobile中的一个关键化合物,在癌症治疗中显示出有前途.
- 丹德罗宾A的抗肝细胞癌 (HCC) 机制尚未完全理解.
研究的目的:
- 为了研究丹德罗宾A的抗HCC作用.
- 阐明潜在的分子机制,重点关注NF-κB信号通路.
主要方法:
- 在体外测试中评估了细胞活力,迁移,入侵,细胞周期,细胞亡和上皮-介质酶过渡.
- mRNA测序确定了差异表达的基因,随后进行了GO和KEGG通路分析.
- 分子对接,西部涂抹和体内实验探索了NF-κB通路和抗瘤效应.
主要成果:
- 登德罗宾A抑制了HCC细胞的增殖,迁移,入侵和上皮细胞-介质细胞过渡,同时诱导了细胞亡和细胞循环停止.
- 确定NF-κB信号传递是关键途径,Dendrobin A与p65和p50蛋白结合,减少它们的激活.
- 在体内研究证实了丹德罗宾A对HCC瘤生长的抑制作用.
结论:
- 丹德罗宾A显示出显著的抗HCC活性.
- 抑制NF-κB通路是登德罗宾A抗癌作用背后的主要机制.
- 这些发现支持Dendrobium nobile在HCC治疗中的治疗潜力.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


